Cryptocurrency & Digital Assets

The aviation finance giant taps new capital pools with a dual-tranche facility, part of a $2.5B haul signaling aggressive growth and market confidence.

Byondis presents two novel ADC platforms at AACR 2026, aiming to solve drug resistance and offer hope for patients unresponsive to immunotherapy.

After two massive data breaches exposed millions, MGM offers Canadian victims a $4M settlement. Here's how to claim your share and what this case reveals.

The premium grocer's new store at Vangohh Eminent signals a major strategic push, raising lifestyle standards amid a shifting Malaysian retail landscape.

The tech firm's new Chennai office signals a major move to capture South India's market, leveraging the city's rich talent pool and robust ecosystem.

On World Hemophilia Day, experts reveal over 75% of people with bleeding disorders are undiagnosed, facing a life of pain without access to basic care.

As Hepsiburada prepares its Q1 results, investors weigh strong growth against mounting losses and fierce competition in Turkey's booming digital market.

A viral 'vapor rub honey trick' is selling a new supplement. We investigate VapoFil's claims and find a stark gap between marketing and science.

Investors eye Darling's Q1 results on April 30 for a rebound in renewable fuel profits and continued strength in its core circular economy segments.

With a final award due by May, Silver Bull Resources' high-stakes legal battle over a blocked mine will test investor protections in Mexico.

A women's wellness brand is the first to earn a rigorous purity award for its beef organ supplement, setting a new benchmark for transparency and safety.

The GTM platform's 142 #1 G2 rankings confirm its market leadership, but a closer look at user feedback reveals a debate over cost and data quality.

As indoor farming pioneer Gotham Greens marks 15 years, a new CEO from the CPG world signals a bold strategy to conquer the entire fresh food aisle.

After a year-long legal battle over alleged fentanyl precursor sales, the U.S. Department of Justice has dismissed all charges against Vasudha Pharma Chem.

New data reveals Mapi Pharma's long-acting GA Depot stabilizes disability in both relapsing and progressive MS, poised for a 2027 European launch.

The Canadian retailer celebrates its milestone not just with deals, but with major investments in local charities, reinforcing its unique community-first model.

Patients, doctors, and researchers unite for a grueling ride across Iceland, raising funds and hope for a future free from multiple myeloma.

Biopharma veteran Glenn Gormley joins Aktis's board, bringing deep ADC expertise to guide the company's next-gen radiopharmaceutical pipeline.

IT giant TD SYNNEX is offering dedicated NVIDIA AI factory access on Nebius Cloud, aiming to solve the GPU scarcity that has stalled enterprise AI.

With Teyana Taylor at the helm, ESSENCE adds Mara Brock Akil, Nikole Hannah-Jones, and Nina Compton to build a deeper, more immersive 2026 festival.